Table 2.
Multiple linear regression analysis for number of MetS components and HOMA-IR
| Characteristics | Number of MetS components | HOMA-IR | ||
|---|---|---|---|---|
| β (P value) | β (P value) | β (P value) | β (P value) | |
| Age (years) | 0.240 (<0.001) | 0.230 (<0.001) | 0.019 (0.541) | −0.031 (0.333) |
| Current smoking status, N (%) | −0.011 (0.701) | −0.012 (0.676) | −0.006 (0.846) | −0.004 (0.887) |
| Alcohol consumption, N (%) | −0.068 (0.020) | −0.066 (0.025) | −0.044 (0.148) | −0.032 (0.293) |
| History of CVD | – | 0.060 (0.032) | – | 0.000 (0.991) |
| Medication | – | – | – | 0.170 (<0.001) |
| Uric acid (mg/dL) | 0.189 (<0.001) | 0.188 (<0.001) | 0.190 (<0.001) | 0.161 (<0.001) |
| hsCRP (mg/dL) | 0.180 (<0.001) | 0.178 (<0.001) | 0.229 (<0.001) | 0.220 (<0.001) |
| R 2 | 0.187 (<0.001) | 0.191 (<0.001) | 0.119 (<0.001) | 0.143 (<0.001) |
Metabolic syndrome (MetS) components were defined as the following conditions: obesity, raised blood pressure, hypertriglyceridemia, low HDL cholesterolemia, and impaired fasting plasma glucose. Medications include antihypertensive, antilipidemic, and antidiabetic medication